Manejo de la diabetes mellitus tipo 2 en adolescentes y adultos jóvenes en atención primaria
| Autor: | F.J. Escobar-Lavado, M.P. Pérez-Unanua, A. Piera-Carbonell, Margarita Alonso-Fernández, Sònia Miravet-Jiménez, B. González-Mohino Loro |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
education.field_of_study
Pediatrics medicine.medical_specialty business.industry Liraglutide Insulin medicine.medical_treatment Population Public Health Environmental and Occupational Health Type 2 diabetes 030204 cardiovascular system & hematology medicine.disease Obesity Diabetic nephropathy 03 medical and health sciences 0302 clinical medicine Insulin resistance Health care medicine 030212 general & internal medicine Family Practice business education medicine.drug |
| Zdroj: | Medicina de Familia. SEMERGEN. 46:415-424 |
| ISSN: | 1138-3593 |
| DOI: | 10.1016/j.semerg.2019.11.008 |
| Popis: | The prevalence of type 2 diabetes (DM2) diagnosed in childhood and adolescence is currently increasing, and is characterised by a rapidly progressive decline in beta-cells and insulin resistance. Physical inactivity and obesity are the main risk factors for its development. Diagnostic criteria are similar to those used in adults, although HbA1c as a diagnostic method is questioned. Diabetes-related complications are more aggressive than in adults. Diabetic nephropathy is the most frequent complication in the young population and macrovascular complications appear early, leading to high mortality rates. Healthy lifestyles are the basis of the treatment, and metformin, insulin and liraglutide (approved by FDA for its use in the United States) are the pharmacological options indicated in this population. It is important to establish models of health care transition from paediatric to adult care to ensure continuity of care and avoid patient disengagements. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|